XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in XBiotech Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- 0 vs. Q2 2023
- Shares held
- 3.34M
- −92.4K (−2.7%) vs. Q2 2023
- Total value
- $14.0M
- −$6.41M (−31.4%) vs. Q2 2023
- New holders
- 3
- 9 more added
- Sold out
- 3
- 10 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $4.56M |
| Q1 2026 | 37 | $4.68M |
| Q4 2025 | 41 | $5.48M |
| Q3 2025 | 48 | $7.81M |
| Q2 2025 | 53 | $10.1M |
| Q1 2025 | 55 | $14.5M |
| Q4 2024 | 53 | $18.6M |
| Q3 2024 | 50 | $37.5M |
| Q2 2024 | 46 | $23.2M |
| Q1 2024 | 46 | $32.5M |
| Q4 2023 | 39 | $13.8M |
| Q3 2023 | 38 | $14.0M |
| Q2 2023 | 39 | $20.7M |
| Q1 2023 | 39 | $8.61M |
| Q4 2022 | 41 | $9.68M |
| Q3 2022 | 45 | $11.1M |
| Q2 2022 | 56 | $18.9M |
| Q1 2022 | 64 | $34.9M |
| Q4 2021 | 61 | $46.8M |
| Q3 2021 | 66 | $56.7M |
| Q2 2021 | 56 | $66.8M |
| Q1 2021 | 65 | $74.1M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding XBiotech Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 164 | $0 | 0.00% | −309−65.3% | Reduced |
| JPMorgan Chase & Co | 38 | $157 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 50 | $206 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 144 | $593 | 0.00% | +17+13.4% | Added |
| Citigroup Inc | 402 | $1.66K | 0.00% | +402 | New |
| McIlrath & Eck, LLC | 753 | $3.10K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 753 | $3.10K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,435 | $6.00K | 0.00% | −1,322−48.0% | Reduced |
| Group One Trading, L.P. | 1,738 | $7.16K | 0.00% | +1,572+947.0% | Added |
| Qube Research & Technologies Ltd | 2,560 | $10.5K | 0.00% | +2,560 | New |
| UBS Group AG | 5,277 | $21.7K | 0.00% | −813−13.3% | Reduced |
| LGT Fund Management Co Ltd. | 10,000 | $38.5K | 0.02% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 10,477 | $43.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,653 | $43.9K | 0.00% | −5,946−35.8% | Reduced |
| BNP Paribas Arbitrage, SA | 10,822 | $44.6K | 0.00% | +1,235+12.9% | Added |
| Synovus Financial Corp | 11,796 | $48.6K | 0.00% | 00.0% | Unchanged |
| Thomasville National Bank | 13,350 | $55.0K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 13,755 | $56.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 15,287 | $63.0K | 0.00% | −13,048−46.0% | Reduced |
| Price T Rowe Associates Inc | 17,600 | $73.0K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 20,040 | $82.6K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 29,200 | $120.3K | 0.00% | −16,200−35.7% | Reduced |
| Two Sigma Investments, LP | 30,840 | $127.1K | 0.00% | −14,200−31.5% | Reduced |
| Susquehanna International Group, LLP | 41,029 | $169.0K | 0.00% | +41,029 | New |
| Northern Trust Corp | 52,748 | $217.3K | 0.00% | +4,788+10.0% | Added |
| Man Group plc | – | $222.5K | 0.00% | – | – |
| Empowered Funds, LLC | 54,200 | $223.3K | 0.01% | +4,424+8.9% | Added |
| Bank of New York Mellon Corp | 55,693 | $229.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 56,526 | $232.9K | 0.00% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 64,318 | $265.0K | 0.00% | +240.0% | Added |
| Dimensional Fund Advisors LP | 72,475 | $298.4K | 0.00% | −1,839−2.5% | Reduced |
| Morgan Stanley | 87,227 | $359.4K | 0.00% | +3,331+4.0% | Added |
| Bridgeway Capital Management, LLC | 139,241 | $573.7K | 0.01% | +12,565+9.9% | Added |
| Geode Capital Management, LLC | 182,738 | $753.1K | 0.00% | +9,557+5.5% | Added |
| Credit Suisse AG | 245,270 | $1.01M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 278,835 | $1.15M | 0.00% | −11,012−3.8% | Reduced |
| Vanguard Group Inc | 872,443 | $3.59M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 931,444 | $3.84M | 0.00% | −28,314−3.0% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,207−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,410−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −5,966−100.0% | Sold out |
| EA Series Trust | – | – | – | – | Not filed |